,i #aagth ,,congress #b;d ,session ,h4 ,r4 #hjch ,,in ,,the ,,house ,,of ,,representatives ,june #ac1 #bjbb,mr4 ,johnson of ,south ,dakota 7for himself1 ,ms4 ,spanberger1 ,mrs4 ,bice of ,oklahoma1 and ,ms4 ,schrier7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to authorize the ,food and ,drug ,administration to require manufacturers of infant formula to warn about a discontinuance or interruption in the production of infant formula1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,formula ,shortage ,reporting ,act of #bjbb4 #b4 ,requirement to warn about discontinuance or interruption in the production of infant formula 7a7 ,in general ,section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7 is amended by adding at the end the following3 7j7 7#a7 ,a manufacturer of infant formula shall notify the ,secretary1 in accordance with paragraph 7#b71 of a permanent discontinuance in the manufacture of the infant formula or an interruption of the manufacture of the infant formula that is likely to lead to a meaningful disruption in the supply of that infant formula in the ,united ,states1 or a permanent discontinuance in the manufacture of an infant formula component or an interruption in the manufacture of an infant formula component that is likely to lead to a meaningful disruption in the supply of the infant formula component1 and the reasons for such discontinuance or interruption4 ,notification under this subsection shall include disclosure of-- 7,a7 reasons for the discontinuance or interruption2 7,b7 if an infant formula component is a reason for1 or a risk factor in1 such discontinuance or interruption1 the source of the infant formula component and any alternative sources for the infant formula component known by the manufacturer2 7,c7 whether any associated device used for preparation or administration included in the infant formula is a reason for1 or a risk factor in1 such discontinuance or interruption2 7,d7 in the case of an interruption1 the expected duration of the interruption2 and 7,e7 such other information as the ,secretary may require4 7#b7 ,a notice required under paragraph 7#a7 shall be submitted to the ,secretary-- 7,a7 at least #gb hours prior to the date of the discontinuance or interruption2 or 7,b7 if compliance with subparagraph 7,a7 is not possible1 as soon as practicable4 7#c7 ,if a manufacturer of infant formula determines that compliance with paragraph 7#b77;,a7 is not possible1 the manufacturer shall submit such determination in writing to the ,secretary and the justification for such determination4 7#d7 ,to the maximum extent practicable1 the ,secretary shall distribute to health care providers who treat pregnant women and children under the age of #b1 and make publicly available on the website of the ,food and ,drug ,administration1 information on the discontinuance or interruption of the manufacture of the infant formula described in paragraph 7#a74 7#e7 ,nothing in this subsection shall be construed as authorizing the ,secretary to disclose any information that is a trade secret or confidential information subject to section #eeb7;b77#d7 of title #e1 ,united ,states ,code1 or section #aije of title #ah1 ,united ,states ,code4 7#f7 ,the ,secretary shall find a manufacturer of infant formula to be in violation of this section if-- 7,a7 the ,secretary determines that-- 7i7 the manufacturer has failed to submit the notice required by paragraph 7#b7 and the determination and justification required by paragraph 7#c72 or 7ii7 the determination and justification submitted by the manufacturer are insufficient2 7,b7 the ,secretary issues a letter to such manufacturer-- 7i7 informing such manufacturer of such failure or insufficiency2 and 7ii7 giving such manufacturer a period of not more than #cj calendar days to correct such failure or insufficiency2 and 7,c7 the ,secretary determines such manufacturer has failed to correct such failure or insufficiency by the end of such period4 7#g7 ,for purposes of this subsection-- 7,a7 the term infant formula component means a raw or in-process material1 ingredient1 container1 or closure used in the manufacturing or processing of infant formula2 7,b7 the term infant formula shortage or shortage1 with respect to an infant formula1 means a period of time when the demand or projected demand for the infant formula within the ,united ,states exceeds the supply of the infant formula2 and 7,c7 the term meaningful disruption-- 7i7 means a change in production that is reasonably likely to lead to a reduction in the supply of an infant formula by a manufacturer that is more than negligible and affects the ability of the manufacturer to fill orders or meet expected demand for its product2 and 7ii7 does not include interruptions in manufacturing due to matters such as routine maintenance or insignificant changes in manufacturing so long as the manufacturer expects to resume operations in a short period of time4 4 7b7 ,prohibited act ,section #cja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cca7 is amended by adding at the end the following3 7fff7 ,the failure by a manufacturer of infant formula1 with respect to a notice of discontinuance or interruption1 to make a correction as required by section #dab7;j77#f77;,c74 4